PRMT2 and glioblastoma: It was later demonstrated that PRMT2 overexpression and the H3R8me2a mark were linked to oncogenic transcriptional programming in glioblastoma multiforme, hepatocellular carcinoma, and renal cell carcinoma, in each case strongly correlating with disease severity (12, 13, 14).